298 related articles for article (PubMed ID: 30706380)
21. Inhibition of estrogen related receptor α attenuates vascular smooth muscle cell proliferation and migration by regulating RhoA/p27
Li Q; Zhu L; Zhang L; Chen H; Zhu Y; Du Y; Zhong W; Zhong M; Shi X
Eur J Pharmacol; 2017 Mar; 799():188-195. PubMed ID: 28213288
[TBL] [Abstract][Full Text] [Related]
22. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
23. The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer.
Du Y; Song L; Zhang L; Ling H; Zhang Y; Chen H; Qi H; Shi X; Li Q
Eur J Med Chem; 2017 Aug; 136():457-467. PubMed ID: 28525844
[TBL] [Abstract][Full Text] [Related]
24. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies.
Ni J; Wu Q; Sun ZH; Zhong J; Cai Y; Huang XE
Asian Pac J Cancer Prev; 2015; 16(11):4571-6. PubMed ID: 26107205
[TBL] [Abstract][Full Text] [Related]
25. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
[TBL] [Abstract][Full Text] [Related]
26. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
He J; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
[TBL] [Abstract][Full Text] [Related]
27. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Prostate Cancer DU-145 Cells Proliferation by
Li X; Tang Y; Yu F; Sun Y; Huang F; Chen Y; Yang Z; Ding G
Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30208576
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790.
Lanvin O; Bianco S; Kersual N; Chalbos D; Vanacker JM
J Biol Chem; 2007 Sep; 282(39):28328-28334. PubMed ID: 17631492
[TBL] [Abstract][Full Text] [Related]
30. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
Aveseh M; Nikooie R; Aminaie M
J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
[TBL] [Abstract][Full Text] [Related]
31. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.
Ji S; Tang S; Li K; Li Z; Liang W; Qiao X; Wang Q; Yu S; Ye M
Toxicol Appl Pharmacol; 2017 Jul; 326():25-33. PubMed ID: 28416456
[TBL] [Abstract][Full Text] [Related]
32. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
[TBL] [Abstract][Full Text] [Related]
33. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
[TBL] [Abstract][Full Text] [Related]
34. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.
Zhang L; Huo X; Liao Y; Yang F; Gao L; Cao L
Sci Rep; 2017 May; 7(1):1669. PubMed ID: 28490807
[TBL] [Abstract][Full Text] [Related]
35. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway.
Hou X; Zhao M; Wang T; Zhang G
Oncol Rep; 2014 Mar; 31(3):1175-82. PubMed ID: 24366110
[TBL] [Abstract][Full Text] [Related]
37. Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation.
Bianco S; Lanvin O; Tribollet V; Macari C; North S; Vanacker JM
J Biol Chem; 2009 Aug; 284(35):23286-92. PubMed ID: 19546226
[TBL] [Abstract][Full Text] [Related]
38. [Regulatory effect of 17beta-estradiol on expression of orphan nuclear receptor ERRalpha in endometrial carcinoma cell lines].
Gao M; Sun PM; Zhao D; Wang JL; Li XP; Wei LH
Ai Zheng; 2006 May; 25(5):538-42. PubMed ID: 16687070
[TBL] [Abstract][Full Text] [Related]
39. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
40. The Glutaminase Inhibitor Compound 968 Exhibits Potent
Guo H; Li W; Pan G; Wang C; Li D; Liu N; Sheng X; Yuan L
Anticancer Agents Med Chem; 2023; 23(2):210-221. PubMed ID: 35570522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]